Glycine Reuptake Inhibition as a New Therapeutic Approach in Schizophrenia: Focus on the Glycine Transporter 1 (GlyT1)

Journal

• Current Pharmaceutical Design

  Current Pharmaceutical Design 19 (7), 1311-1320, 2012-12-01

  Bentham Science Publishers Ltd.